OS Therapies to Present at BioFuture 2025 and Discuss OST-HER2 Clinical Development

OS Therapies Inc. announces its participation in the BioFuture 2025 conference, where it will present an overview of the company with a focus on the c...
Home/KnloSights/Clinical Trial Updates/OS Therapies to Present at BioFuture 2025 and Discuss OST-HER2 Clinical Development